Fingerprint
Dive into the research topics of 'Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome–negative acute lymphoblastic leukemia in first salvage'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically